Oxford and AstraZeneca resume COVID-19 vaccine trial

LONDON (AP) — Oxford University announced Saturday it was resuming a trial for a coronavirus vaccine it is developing with pharmaceutical company AstraZeneca, a move that comes days after the study was suspended following a reported side-effect in a U.K. patient. In a statement, the university confirmed the restart across all of its U.K. clinical...

from News | New York Post https://ift.tt/3ir1Hne